Development of Drug-resistant Cell Lines for Experimental Procedures
Journal of Visualized Experiments · 12.08.2025 · (222)
DOI: 10.3791/68957 ↗Kurz gefasst
Video/Audio in der Zeitschrift Journal of Visualized Experiments, online erschienen am 12.08.2025. Verfasst von Suguru Kadomoto und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, University of Michigan, Ann Arbor; Department of Urology, Kanazawa University. Hauptthemen laut MEDLINE: Drug Resistance, Neoplasm, Antineoplastic Agents. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 12 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS.
Abstract (Originalsprache)
The development of drug-resistant cell lines is essential for understanding the mechanisms of drug resistance and identifying strategies to overcome treatment failure in cancer therapy. Resistance models enable preclinical evaluation of novel compounds, repurposed drugs, and combination therapies. To generate resistant cells, parental cancer cell lines are repeatedly exposed to incrementally increasing concentrations of the target drug over several weeks. Cells that survive and proliferate at each stage are selected, expanded, and exposed to higher drug doses. The development of resistance is confirmed by quantifying and comparing the half-maximal inhibitory concentration (IC50) values between parental and resistant cells using cell viability assays and nonlinear regression analysis. Significantly increased IC50 values indicate successful adaptation to drug pressure and the development of resistance. These drug-resistant cell lines are available for comprehensive analysis, such as microarray and single-cell sequencing, as well as various in vitro or in vivo experiments. These models provide valuable tools for investigating potential therapeutic strategies to overcome drug resistance.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Urology, University of Michigan, Ann Arbor; Department of Urology, Kanazawa University.
- Department of Urology, University of Michigan, Ann Arbor.
- Department of Urology, Kanazawa University.
- Department of Urology, University of Michigan, Ann Arbor; Biointerfaces Institute, University of Michigan, Ann Arbor; Single Cell Spatial Analysis Program, University of Michigan, Ann Arbor; etkeller@med.umich.edu.
Förderung
- NCI NIH HHS
Zitieren
APA
Kadomoto, S., Shelley, G., Mizokami, A., & Keller, E. T. (2025). Development of Drug-resistant Cell Lines for Experimental Procedures. Journal of Visualized Experiments. https://doi.org/10.3791/68957
Vancouver
Kadomoto S, Shelley G, Mizokami A, Keller ET. Development of Drug-resistant Cell Lines for Experimental Procedures. Journal of Visualized Experiments. 2025. doi:10.3791/68957
BibTeX
@article{Kadomoto2025,
author = {Kadomoto, Suguru and Shelley, Greg and Mizokami, Atsushi and Keller, Evan T},
title = {Development of Drug-resistant Cell Lines for Experimental Procedures},
journal = {Journal of Visualized Experiments},
year = {2025},
number = {222},
doi = {10.3791/68957}
}
EUVIMED